FDA'S CME POLICY ALLOWS SOME DISCUSSION OF DEVICE, DRUG UNAPPROVED USES
This article was originally published in The Gray Sheet
Executive Summary
FDA'S CME POLICY ALLOWS SOME DISCUSSION OF DEVICE, DRUG UNAPPROVED USES FDA asserts in a Nov. 18 Federal Register notice. The notice solicits comments on a petition filed by the Washington Legal Foundation in October 1993 which asserted that the FDA policy on industry-supported continuing medical education violates First Amendment free-speech rights and should be withdrawn.